Sonim Q3 revenue up 30.4% sequentially to $15.0M; net loss narrows to $2.5M

DNA X, Inc.

2024-Q3 EPS reported -$2.58 vs consensus -$12.12 ▲ beat (+78.7%)

Net revenue $15.0M, up 30.4% from Q2 2024; GAAP net loss $2.5M vs. $6.6M in Q2 including $3.2M impairment.
Adjusted EBITDA negative $1.1M, improved from negative $2.0M in prior quarter. Cash $9.1M.
Launched H700 5G rugged mobile hotspot in Australia and H500 5G hotspot with Verizon Wireless in North America.
Secured major device upgrade agreement with a leading Fortune 500 food and beverage company.
Unveiled XP400 smartphone and XP100 feature phone for European and South African markets.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.